| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 55.785 | 82.179 | 92.379 | 104.888 | 120.784 | 120.463 | 132.098 |
| Total Income - EUR | - | - | - | 55.785 | 82.179 | 92.379 | 104.888 | 120.784 | 120.469 | 132.098 |
| Total Expenses - EUR | - | - | - | 10.923 | 12.004 | 12.372 | 17.248 | 21.864 | 20.615 | 21.116 |
| Gross Profit/Loss - EUR | - | - | - | 44.862 | 70.175 | 80.007 | 87.640 | 98.921 | 99.855 | 110.982 |
| Net Profit/Loss - EUR | - | - | - | 44.304 | 69.353 | 79.083 | 86.612 | 97.713 | 98.650 | 107.019 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Mednantoy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 20.803 | 16.634 | 12.626 | 8.735 | 5.141 | 1.515 | 10 |
| Current Assets | - | - | - | 100.876 | 164.990 | 240.970 | 100.389 | 101.917 | 101.148 | 119.915 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 745 | 731 | 14.256 | 78.183 | 94.537 | 92.473 | 115.154 |
| Cash | - | - | - | 100.130 | 164.259 | 226.714 | 22.206 | 7.379 | 8.675 | 4.760 |
| Shareholders Funds | - | - | - | 103.050 | 170.407 | 246.260 | 86.660 | 97.762 | 98.698 | 107.068 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 18.629 | 11.216 | 7.336 | 22.464 | 9.296 | 3.964 | 12.857 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mednantoy S.r.l.